In-House Impact: Biopharma Summit

Tailored for General Counsels and Chief Legal Officers at drug development companies, this intimate, peer-led summit empowers you to elevate legal as a business-critical function. Learn how in-house teams are adapting to economic volatility, harnessing new legal tech, and navigating cross-functional leadership demands, all while building a valuable network of peers.

This is not just another conference. It's a strategic inflection point. Free to attend for biopharma's in-house counsel, this event will help you transition from a traditional lawyer to a corporate leader, ready to drive business success.

URLs:

• Tickets: https://go.evvnt.com/3049692-1?pid=10008
• Brochure: https://go.evvnt.com/3049692-2?pid=10008

Time: 9:00 AM - 5:00 PM

Prices:

• Biopharma In-House Legal Counsel: USD 0.50,
• Solution Provider Pricing: USD 3699.00

Speakers: Andrew Reardon, Chief Legal Officer, Ligand Pharmaceuticals, Benjamin Hsing, President, Asian American Bar Association of New York, Darin Lippoldt, Chief Legal Officer, Neurocrine Biosciences, Dario Scimeca, General Counsel, Precision BioSciences, Elbert Chiang, Vice President, Intellectual Property, Beam Therapeutics, Gregory Montalbano, Associate General Counsel and Head, Compliance, Assertio Therapeutics, Guled Adam, General Counsel, Sobi NA, James Singleton, General Counsel, Numab Therapeutics, Jenny Robertson, Chief Business and Legal Officer, Lexeo Therapeutics, Jessica Sergi, Associate General Counsel, EMD Serono, Joseph Barry, General Counse, Merz Pharmaceuticals, Kara DelTufo, Senior Director, Associate General Counsel, Foundation Medicine, Rupa Cornell, Vice President and Head Counsel for Vaccine Business Unit, Takeda Pharmaceutical, Shannon Moesaa, Senior Vice President, Legal, Ardelyx, Shawnte Mitchell, Chief Legal Officer; Corporate Secretary, Olema Oncology, Tamara Tompkins, Chief Legal Officer, Insitro, Teresa Bair, Chief Legal Officer, Kura Oncology